Alpa Laboratories Limited

NSE:ALPA.NS

111.64 (INR) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q3
Revenue 214.437236.066273.083323.945254.296291.584273.134135.449224.195234.105293.284262.55315.194238.468331.642231.079162.946170.641241.264235.128201.671175.281259.605159.077164.582125.28682.635145.191138.153189.949100.643184.552146.507137.29598.529190.584120.183119.279132.189146.734178.601
Cost of Revenue 188.91168.45219.696223.195217.288138.011183.386145.114165.249161.596194.819176.269228.186179.935212.027159.19996.39396.341154.093167.454134.864144.021172.427103.049107.14635.75221.151137.90479.45131.06651.687157.32870.67192.38845.873161.19771.27780.30990.519135.521140.837
Gross Profit 25.52767.61653.387100.7537.008153.57389.748-9.66558.94672.50998.46586.28187.00858.533119.61571.8866.55374.387.17167.67466.80731.2687.17856.02857.43689.53461.4847.28758.70358.88348.95627.22475.83644.90752.65629.38748.90638.9741.6711.21237.764
Gross Profit Ratio 0.1190.2860.1950.3110.1460.5270.329-0.0710.2630.310.3360.3290.2760.2450.3610.3110.4080.4350.3610.2880.3310.1780.3360.3520.3490.7150.7440.050.4250.310.4860.1480.5180.3270.5340.1540.4070.3270.3150.0760.211
Reseach & Development Expenses 00000000000000000000000000000000000000000
General & Administrative Expenses 0000021.15800033.71100028.27500033.7800038.9470000014.3850006.1870006.05100000
Selling & Marketing Expenses 000003.1070002.7730001.9930002.5160004.7770000025.35200028.49600019.19700000
SG&A 25.64937.79135.6834.73929.70124.26534.28119.38527.42536.48428.70928.82532.81930.26837.26727.76524.90536.29629.22827.96928.13443.72428.4927.45426.8330081.54416.73719.46621.28478.34818.91419.63117.99862.53818.02212.781000
Other Expenses 51.60239.65335.32329.52944.392-6.85326.70363.33416.143-89.89922.01226.68442.686-36.81911.2838.99317.06-20.27211.6042.6727.058-28.4785.94211.396027.88830.10840.07528.81966.01865.31338.13169.65566.34860.31642.56460.36237.85934.19911.6431.201
Operating Expenses 25.64937.79135.6872.14951.18466.76864.52450.83847.72463.41765.55955.19564.67817.40793.4257.31551.27351.23272.69766.03260.84552.58967.74863.26647.42327.88830.10840.07528.81966.01865.31338.13169.65566.34860.31642.56460.36237.85934.19911.6431.201
Operating Income -0.12229.82517.70758.13130.21679.95251.9272.8327.3663.73832.90631.08722.3341.12626.19514.56515.2823.06814.4741.6425.962-21.32919.43-7.238-1.48961.64631.376-32.78829.884-7.135-16.357-10.9076.181-21.441-7.66-13.177-11.4561.1117.471-0.4276.563
Operating Income Ratio -0.0010.1260.0650.1790.1190.2740.190.0210.1220.0160.1120.1180.0710.1720.0790.0630.0940.1350.060.0070.03-0.1220.075-0.045-0.0090.4920.38-0.2260.216-0.038-0.163-0.0590.042-0.156-0.078-0.069-0.0950.0090.057-0.0030.037
Total Other Income Expenses Net 51.08436.88735.258-0.2370.114-0.355-0.735-0.81-0.33316.06521.17426.06442.258-25.94111.1028.70616.831-35.77911.3172.2236.1625.9574.9049.2349.515-2.963-1.70713.567-3.563-5.214-5.511-0.009-5.82-5.053-4.799-2.03-6.685-4.504-3.0322.086-2.754
Income Before Tax 50.96266.71252.96557.89430.3379.59751.1922.0227.03319.80454.0857.15264.58815.18537.29723.27132.111-12.71125.7913.86512.124-15.37224.3341.9968.02758.68329.669-19.22126.321-12.349-21.868-10.9160.361-26.494-12.459-15.207-18.141-3.3934.4391.6583.809
Income Before Tax Ratio 0.2380.2830.1940.1790.1190.2730.1870.0150.1210.0850.1840.2180.2050.0640.1120.1010.197-0.0740.1070.0160.06-0.0880.0940.0130.0490.4680.359-0.1320.191-0.065-0.217-0.0590.002-0.193-0.126-0.08-0.151-0.0280.0340.0110.021
Income Tax Expense 031.1817.8744.8072.71333.0750.9963.4780.00154.7170.03-0.01542.68635.40911.2838.992-0.015-25.91311.5922.6727.05817.0850.56211.3940.93700-13.14141.736000.556100.4810.77800.77603.0560
Net Income 50.96235.35545.09157.89430.3346.02651.1922.0227.032-34.91454.0857.16764.588-20.22437.29723.27132.127-23.25225.7973.86512.124-32.45823.7721.9968.96458.68329.66935.655-15.415-12.349-21.868-11.471-0.639-26.494-12.939-25.985-18.141-4.1694.439-1.3973.809
Net Income Ratio 0.2380.150.1650.1790.1190.1580.1870.0150.121-0.1490.1840.2180.205-0.0850.1120.1010.197-0.1360.1070.0160.06-0.1850.0920.0130.0540.4680.3590.246-0.112-0.065-0.217-0.062-0.004-0.193-0.131-0.136-0.151-0.0350.034-0.010.021
EPS 2.421.712.142.751.442.212.430.11.29-1.662.572.723.06-0.961.771.141.53-1.111.230.180.58-1.551.130.090.432.791.411.7-0.73-0.59-1.04-0.55-0.03-1.26-0.61-1.24-0.86-0.20.21-0.0670.18
EPS Diluted 2.421.712.142.751.442.212.430.11.29-1.632.572.723.06-0.961.771.141.53-1.111.230.180.58-1.551.130.090.432.791.411.7-0.73-0.59-1.04-0.55-0.03-1.26-0.61-1.24-0.86-0.20.21-0.0670.18
EBITDA 5.30635.07224.32563.0632.97185.24952.956.39430.73423.96259.2561.97368.07518.26540.54326.45435.15-5.01333.99612.09620.586-8.11433.35912.0471.1363.68933.225-0.01431.35813.2113.99611.70629.1961.29814.5669.9978.0933.42710.5482.1419.094
EBITDA Ratio 0.0250.1490.0890.1950.130.2920.1940.0470.1370.1020.2020.2360.2160.0770.1220.1140.216-0.0290.1410.0510.102-0.0460.1280.0760.0070.5080.402-00.2270.070.040.0630.1990.0090.1480.0520.0670.0290.080.0150.051